14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $2.47 Thursday, 25th Apr 2024 AKBA stock ended at $1.33. This is 2.92% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.05% from a day low at $1.31 to a day high of $1.35.
90 days $1.31 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Feb 18, 2021 $4.60 $4.70 $4.27 $4.31 8 652 271
Feb 17, 2021 $4.89 $4.91 $4.57 $4.61 6 636 746
Feb 16, 2021 $4.74 $5.05 $4.61 $4.87 8 502 209
Feb 12, 2021 $4.67 $4.78 $4.54 $4.61 4 149 084
Feb 11, 2021 $4.64 $4.90 $4.52 $4.77 6 206 381
Feb 10, 2021 $4.95 $5.06 $4.41 $4.62 9 353 758
Feb 09, 2021 $5.00 $5.08 $4.73 $4.85 8 617 596
Feb 08, 2021 $4.57 $5.14 $4.37 $5.06 14 638 378
Feb 05, 2021 $3.99 $4.56 $3.86 $4.51 10 365 328
Feb 04, 2021 $4.15 $4.39 $3.81 $3.87 12 776 599
Feb 03, 2021 $3.50 $4.02 $3.48 $3.94 9 679 363
Feb 02, 2021 $3.45 $3.64 $3.37 $3.50 7 452 924
Feb 01, 2021 $3.27 $3.44 $3.17 $3.41 6 238 993
Jan 29, 2021 $3.36 $3.39 $3.19 $3.24 7 414 330
Jan 28, 2021 $3.57 $3.75 $3.41 $3.43 6 177 013
Jan 27, 2021 $3.55 $3.73 $3.44 $3.49 8 189 602
Jan 26, 2021 $3.81 $3.86 $3.70 $3.76 7 803 377
Jan 25, 2021 $3.48 $3.93 $3.46 $3.71 11 947 539
Jan 22, 2021 $3.15 $3.40 $3.10 $3.36 6 496 548
Jan 21, 2021 $3.22 $3.24 $3.11 $3.15 6 283 766
Jan 20, 2021 $3.19 $3.29 $3.10 $3.17 9 824 146
Jan 19, 2021 $3.12 $3.22 $3.04 $3.14 5 988 141
Jan 15, 2021 $3.14 $3.16 $3.04 $3.05 4 192 658
Jan 14, 2021 $3.13 $3.20 $3.10 $3.17 5 203 026
Jan 13, 2021 $3.07 $3.25 $2.97 $3.11 16 723 435
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT